Literature DB >> 1510452

Stereochemical evaluation of the relative activities of the cinchona alkaloids against Plasmodium falciparum.

J M Karle1, I L Karle, L Gerena, W K Milhous.   

Abstract

Quinine and quinidine were over 100 times more active than 9-epiquinine and 9-epiquinidine against chloroquine-sensitive Plasmodium falciparum and over 10 times more active against chloroquine-resistant P. falciparum. Since the only structural difference between quinine, quinidine, 9-epiquinine, and 9-epiquinidine is their three-dimensional configuration, the three-dimensional structures of these four alkaloids were examined in order to explain the large difference in relative activities between the 9-epi alkaloids and quinine and quinidine. The crystal structure of 9-epiquinidine hydrochloride monohydrate was determined by X-ray diffraction and was compared with the crystal structures of quinine, quinidine sulfate dihydrate, and 9-epiquinine hydrochloride dihydrate. The crystallographic parameters for 9-epiquinidine hydrochloride monohydrate were as follows: chemical formula, C20H25N2O2+.Cl-.H2O; M(r), 378.9; symmetry of unit cell, orthorhombic; space group, P2(1)2(1)2(1); parameters of unit cell, a was 7.042 +/- 0.001 A (1 A = 0.1 nm), b was 9.082 +/- 0.001 A, c was 31.007 +/- 0.005 A; the volume of unit cell was 1,983.1 +/- 0.6 A3; number of molecules per unit cell was 4; the calculated density was 1.27 g cm-3; the source of radiation was Cu K alpha (lambda = 1.54178 A); mu (absorption coefficient) was 18.82 cm-1; F(000) (sum of atomic scattering factors at zero scattering angle) was 808; room temperature was used; final R (residual index) was 5.72% for 1,501 reflections with magnitude of F(o) greater than 3 sigma (F). The intramolecular distance from N-1 to O-12 in 9-epiquinidine and 9-epiquinine, although shorter than the corresponding distance in quinine and quinidine, was similar to those of other active amino alcohol antimalarial agents. In all four alkaloids, both the hydroxyl and amine groups formed intermolecular hydrogen bonds, showing the potential for forming hydrogen bonds with cellular constituents. However, the positioning of the N+-1--H-N1 and O-12--H-O12 groups relative to each other was quite different in the 9-epi alkaloids versus quinidine. This difference in positioning may determine the relative strengths, of the formation of hydrogen bonds with cellular constituents important to antimalarial activity and, therefore, may determine the relative strength of antimalarial activity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1510452      PMCID: PMC191617          DOI: 10.1128/AAC.36.7.1538

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

1.  The action of the cinchona and certain other alkaloids in bird malaria. III.

Authors:  G A Buttle; T A Henry; W Solomon; J W Trevan; E M Gibbs
Journal:  Biochem J       Date:  1938-01       Impact factor: 3.857

2.  STUDIES ON THE CHEMOTHERAPY OF THE HUMAN MALARIAS. III. THE PHYSIOLOGICAL DISPOSITION AND ANTIMALARIAL ACTIVITY OF THE CINCHONA ALKALOIDS.

Authors:  J V Taggart; D P Earle; R W Berliner; C G Zubrod; W J Welch; N B Wise; E F Schroeder; I M London; J A Shannon
Journal:  J Clin Invest       Date:  1948-05       Impact factor: 14.808

3.  A comparison of the antimalarial activity of the cinchona alkaloids against Plasmodium falciparum in vitro.

Authors:  D L Wesche; J Black
Journal:  J Trop Med Hyg       Date:  1990-06

Review 4.  In vitro strategies for circumventing antimalarial drug resistance.

Authors:  W K Milhous; L Gerena; D E Kyle; A M Oduola
Journal:  Prog Clin Biol Res       Date:  1989

5.  In vitro activities of and mechanisms of resistance to antifol antimalarial drugs.

Authors:  W K Milhous; N F Weatherly; J H Bowdre; R E Desjardins
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

6.  Quinidine in falciparum malaria.

Authors:  N J White; S Looareesuwan; D A Warrell; T Chongsuphajaisiddhi; D Bunnag; T Harinasuta
Journal:  Lancet       Date:  1981-11-14       Impact factor: 79.321

7.  Crystal structure and molecular structure of mefloquine methylsulfonate monohydrate: implications for a malaria receptor.

Authors:  J M Karle; I L Karle
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

8.  Plasmodium falciparum: cloning by single-erythrocyte micromanipulation and heterogeneity in vitro.

Authors:  A M Oduola; N F Weatherly; J H Bowdre; R E Desjardins
Journal:  Exp Parasitol       Date:  1988-06       Impact factor: 2.011

9.  Intravenous quinidine for the treatment of severe falciparum malaria. Clinical and pharmacokinetic studies.

Authors:  R E Phillips; D A Warrell; N J White; S Looareesuwan; J Karbwang
Journal:  N Engl J Med       Date:  1985-05-16       Impact factor: 91.245

10.  The disposition of quinine in the rat isolated perfused liver: effect of dose size.

Authors:  M D Coleman; G Timony; L Fleckenstein
Journal:  J Pharm Pharmacol       Date:  1990-01       Impact factor: 3.765

View more
  9 in total

1.  The hydroxyl functionality and a rigid proximal N are required for forming a novel non-covalent quinine-heme complex.

Authors:  John N Alumasa; Alexander P Gorka; Leah B Casabianca; Erica Comstock; Angel C de Dios; Paul D Roepe
Journal:  J Inorg Biochem       Date:  2010-09-22       Impact factor: 4.155

Review 2.  Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications.

Authors:  S Krishna; N J White
Journal:  Clin Pharmacokinet       Date:  1996-04       Impact factor: 6.447

3.  Crystal structure of (-)-mefloquine hydrochloride reveals consistency of configuration with biological activity.

Authors:  Jean M Karle; Isabella L Karle
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

4.  Investigating the activity of quinine analogues versus chloroquine resistant Plasmodium falciparum.

Authors:  Theresa Dinio; Alexander P Gorka; Andrew McGinniss; Paul D Roepe; Jeremy B Morgan
Journal:  Bioorg Med Chem       Date:  2012-03-29       Impact factor: 3.641

Review 5.  Stereoselectivity in the pharmacodynamics and pharmacokinetics of the chiral antimalarial drugs.

Authors:  Dion R Brocks; Reza Mehvar
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

6.  Mutation in the Plasmodium falciparum CRT protein determines the stereospecific activity of antimalarial cinchona alkaloids.

Authors:  Carol E Griffin; Jonathan M Hoke; Upeka Samarakoon; Junhui Duan; Jianbing Mu; Michael T Ferdig; David C Warhurst; Roland A Cooper
Journal:  Antimicrob Agents Chemother       Date:  2012-08-06       Impact factor: 5.191

7.  Relative to quinine and quinidine, their 9-epimers exhibit decreased cytostatic activity and altered heme binding but similar cytocidal activity versus Plasmodium falciparum.

Authors:  Alexander P Gorka; Katy S Sherlach; Angel C de Dios; Paul D Roepe
Journal:  Antimicrob Agents Chemother       Date:  2012-10-31       Impact factor: 5.191

8.  The relationship of physico-chemical properties and structure to the differential antiplasmodial activity of the cinchona alkaloids.

Authors:  David C Warhurst; John C Craig; Ipemida S Adagu; David J Meyer; Sylvia Y Lee
Journal:  Malar J       Date:  2003-09-01       Impact factor: 2.979

Review 9.  Recent advances in the discovery of haem-targeting drugs for malaria and schistosomiasis.

Authors:  Katherine A de Villiers; Timothy J Egan
Journal:  Molecules       Date:  2009-08-04       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.